Candida albicans biofilms: development, regulation, and molecular mechanisms

Microbes and Infection

Volumn 18, Issue 5, 2016, Pages 310-321

  Gulati, Megha ^a   Nobile, Clarissa J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biofilm; Candida albicans; Fungi; Microbial community; Pathogen; Transcriptional regulation

Indexed keywords

ANTIFUNGAL AGENT;

ANTIFUNGAL RESISTANCE; BIOFILM; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; CELL SURFACE; ENVIRONMENT; ENVIRONMENTAL FACTOR; EXTRACELLULAR MATRIX; FUNGAL GENETICS; FUNGAL VIRULENCE; GENETIC REGULATION; HOST; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; MUCUS; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; PHYSIOLOGY; VIRULENCE;

BIOFILMS; CANDIDA ALBICANS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; VIRULENCE;

EID: 84956885413     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2016.01.002     Document Type: Short Survey

References (78)

1. [1] Nobile, C.J., Johnson, A.D., Candida albicans biofilms and human disease. Annu Rev Microbiol 69 (2015), 71–92.
2. [2] Davey, M.E., O'toole, G.A., Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 64 (2000), 847–867.
3. [3] Kolter, R., Greenberg, E.P., Microbial sciences: the superficial life of microbes. Nature 441 (2006), 300–302.
4. [4] Jass, J., Surman, S., Walker, J., Medical Biofilms Detection, Prevention, and Control. 2003, John Wiley & Sons, Ltd, Chichester, UK.
5. [5] Hall-Stoodley, L., Costerton, J.W., Stoodley, P., Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2 (2004), 95–108.
6. [6] Fox, E.P., Nobile, C.J., The role of Candida albicans biofilms in human disease. Dietrich, L.A., Friedmann, T.S., (eds.) Candida albicans symptoms, causes and treatment options, 2013, Nova Science Publishers, 1–24.
7. [7] Fox, E.P., Nobile, C.J., A sticky situation: untangling the transcriptional network controlling biofilm development in Candida albicans. Transcription 3 (2012), 315–322.
8. [8] Ganguly, S., Mitchell, A.P., Mucosal biofilms of Candida albicans. Curr Opin Microbiol 14 (2011), 380–385.
9. [9] Douglas, L.J., Candida biofilms and their role in infection. Trends Microbiol 11 (2003), 30–36.
10. [10] Kojic, E.M., Darouiche, R.O., Candida infections of medical devices. Clin Microbiol Rev 17 (2004), 255–267.
11. [11] Chandra, J., Kuhn, D.M., Mukherjee, P.K., Hoyer, L.L., McCormick, T., Ghannoum, M.A., Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183 (2001), 5385–5394.
12. [12] Fox, E.P., Singh-babak, S.D., Hartooni, N., Nobile, C.J., Biofilms and antifungal resistance. Coste, A.T., Vandeputte, P., (eds.) Antifungals from genomics to resistance and the development of novel agents, 2015, Caister Academic Press, 71–90.
13. [13] Andes, D.R., Safdar, N., Baddley, J.W., Playford, G., Reboli, A.C., Rex, J.H., et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54 (2012), 1110–1122.
14. [14] Tournu, H., Van Dijck, P., Candida biofilms and the host: models and new concepts for eradication. Int J Microbiol, 2012, 2012, 845352.
15. [15] Andes, D., Nett, J., Oschel, P., Albrecht, R., Marchillo, K., Pitula, A., Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 72 (2004), 6023–6031.
16. [16] Johnson, C.C., Yu, A., Lee, H., Fidel, P.L. Jr., Noverr, M.C., Development of a contemporary animal model of Candida albicans-associated denture stomatitis using a novel intraoral denture system. Infect Immun 80 (2012), 1736–1743.
17. [17] Nett, J.E., Brooks, E.G., Cabezas-Olcoz, J., Sanchez, H., Zarnowski, R., Marchillo, K., et al. Rat indwelling urinary catheter model of Candida albicans biofilm infection. Infect Immun 82 (2014), 4931–4940.
18. [18] Harriott, M.M., Lilly, E.A., Rodriguez, T.E., Fidel, P.L., Noverr, M.C., Candida albicans forms biofilms on the vaginal mucosa. Microbiology 156 (2010), 3635–3644.
19. [19] Dongari-Bagtzoglou, A., Kashleva, H., Dwivedi, P., Diaz, P., Vasilakos, J., Characterization of mucosal Candida albicans biofilms. PLoS One, 4, 2009, e7967.
20. [20] Ricicova, M., Kucharikova, S., Tournu, H., Hendrix, J., Bujdakova, H., Van Eldere, J., et al. Candida albicans biofilm formation in a new in vivo rat model. Microbiology 156 (2010), 909–919.
21. [21] Doyle, T.C., Nawotka, K.A., Kawahara, C.B., Francis, K.P., Contag, P.R., Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene. Microb Pathog 40 (2006), 82–90.
22. [22] Vande Velde, G., Kucharikova, S., Schrevens, S., Himmelreich, U., Van Dijck, P., Towards non-invasive monitoring of pathogen-host interactions during Candida albicans biofilm formation using in vivo bioluminescence. Cell Microbiol 16 (2014), 115–130.
23. [23] Vande Velde, G., Kucharikova, S., Van Dijck, P., Himmelreich, U., Bioluminescence imaging of fungal biofilm development in live animals. Methods Mol Biol 1098 (2014), 153–167.
24. [24] Martinez-Gomariz, M., Perumal, P., Mekala, S., Nombela, C., Chaffin, W.L., Gil, C., Proteomic analysis of cytoplasmic and surface proteins from yeast cells, hyphae, and biofilms of Candida albicans. Proteomics 9 (2009), 2230–2252.
25. [25] Zarnowski, R., Westler, W.M., Lacmbouh, G.A., Marita, J.M., Bothe, J.R., Bernhardt, J., et al. Novel entries in a fungal biofilm matrix encyclopedia. MBio, 5, 2014 e01333–14.
26. [26] Nobile, C.J., Fox, E.P., Nett, J.E., Sorrells, T.R., Mitrovich, Q.M., Hernday, A.D., et al. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148 (2012), 126–138.
27. [27] Bonhomme, J., d'Enfert, C., Candida albicans biofilms: building a heterogeneous, drug-tolerant environment. Curr Opin Microbiol 16 (2013), 398–403.
28. [28] Ni, L., Bruce, C., Hart, C., Leigh-Bell, J., Gelperin, D., Umansky, L., et al. Dynamic and complex transcription factor binding during an inducible response in yeast. Genes Dev 23 (2009), 1351–1363.
29. [29] Hernday, A.D., Lohse, M.B., Fordyce, P.M., Nobile, C.J., DeRisi, J.L., Johnson, A.D., Structure of the transcriptional network controlling white-opaque switching in Candida albicans. Mol Microbiol 90 (2013), 22–35.
30. [30] Nobile, C.J., Mitchell, A.P., Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol 15 (2005), 1150–1155.
31. [31] Nobile, C.J., Nett, J.E., Andes, D.R., Mitchell, A.P., Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 5 (2006), 1604–1610.
32. [32] Nobile, C.J., Schneider, H.A., Nett, J.E., Sheppard, D.C., Filler, S.G., Andes, D.R., et al. Complementary adhesin function in C. albicans biofilm formation. Curr Biol 18 (2008), 1017–1024.
33. [33] Nobile, C.J., Andes, D.R., Nett, J.E., Smith, F.J., Yue, F., Phan, Q.T., et al. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog, 2, 2006, e63.
34. [34] Finkel, J.S., Xu, W., Huang, D., Hill, E.M., Desai, J.V., Woolford, C.A., et al. Portrait of Candida albicans adherence regulators. PLoS Pathog, 8, 2012, e1002525.
35. [35] Ramage, G., VandeWalle, K., Lopez-Ribot, J.L., Wickes, B.L., The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 214 (2002), 95–100.
36. [36] Xu, H., Jenkinson, H.F., Dongari-Bagtzoglou, A., Innocent until proven guilty: mechanisms and roles of Streptococcus-Candida interactions in oral health and disease. Mol Oral Microbiol 29 (2014), 99–116.
37. [37] Nett, J.E., Zarnowski, R., Cabezas-Olcoz, J., Brooks, E.G., Berhardt, J., Marchillo, K., et al. Host contributions to construction of three device-associated Candida biofilms. Infect Immun 83 (2015), 4630–4638.
38. [38] Nobile, C.J., Mitchell, A.P., Microbial biofilms: e pluribus unum. Curr Biol 17 (2007), R349–R353.
39. [39] Nett, J.E., Sanchez, H., Cain, M.T., Ross, K.M., Andes, D.R., Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation. Eukaryot Cell 10 (2011), 1660–1669.
40. [40] Nobile, C.J., Nett, J.E., Hernday, A.D., Homann, O.R., Deneault, J.S., Nantel, A., et al. Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol, 7, 2009, e1000133.
41. [41] Uppuluri, P., Chaturvedi, A.K., Srinivasan, A., Banerjee, M., Ramasubramaniam, A.K., Kohler, J.R., et al. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog, 6, 2010, e1000828.
42. [42] Uppuluri, P., Pierce, C.G., Thomas, D.P., Bubeck, S.S., Saville, S.P., Lopez-Ribot, J.L., The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion. Eukaryot Cell 9 (2010), 1531–1537.
43. [43] Nobile, C.J., Fox, E.P., Hartooni, N., Mitchell, K.F., Hnisz, D., Andes, D.R., et al. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans. MBio 5 (2014), e01201–e01214.
44. [44] Hnisz, D., Bardet, A.F., Nobile, C.J., Petryshyn, A., Glaser, W., Schock, U., et al. A histone deacetylase adjusts transcription kinetics at coding sequences during Candida albicans morphogenesis. PLoS Genet, 8, 2012, e1003118.
45. [45] Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J.L., et al. Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog, 7, 2011, e1002257.
46. [46] Shapiro, R.S., Uppuluri, P., Zaas, A.K., Collins, C., Senn, H., Perfect, J.R., et al. Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling. Curr Biol 19 (2009), 621–629.
47. [47] Granger, B.L., Insight into the antiadhesive effect of yeast wall protein 1 of Candida albicans. Eukaryot Cell 11 (2012), 795–805.
48. [48] Savage, D.C., Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31 (1977), 107–133.
49. [49] Peleg, A.Y., Hogan, D.A., Mylonakis, E., Medically important bacterial-fungal interactions. Nat Rev Microbiol 8 (2010), 340–349.
50. [50] Peters, B.M., Noverr, M.C., Candida albicans–Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity. Infect Immun 81 (2013), 2178–2189.
51. [51] Jarosz, L.M., Deng, D.M., van der Mei, H.C., Crielaard, W., Krom, B.P., Streptococcus mutans competence-stimulating peptide inhibits Candida albicans hypha formation. Eukaryot Cell 8 (2009), 1658–1664.
52. [52] Bamford, C.V., d'Mello, A., Nobbs, A.H., Dutton, L.C., Vickerman, M.M., Jenkinson, H.F., Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect Immun 77 (2009), 3696–3704.
53. [53] Jack, A.A., Daniels, D.E., Jepson, M.A., Vickerman, M.M., Lamont, R.J., Jenkinson, H.F., et al. Streptococcus gordonii comCDE (competence) operon modulates biofilm formation with Candida albicans. Microbiology 161 (2015), 411–421.
54. [54] Lindsay, A.K., Hogan, D.A., Candida albicans: molecular interactions with Pseudomonas aeruginosa and Staphylococcus aureus. Fungal Biol Rev 28 (2014), 85–96.
55. [55] Neely, A.N., Law, E.J., Holder, I.A., Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes. Infect Immun 52 (1986), 200–204.
56. [56] Bandara, H.M., Yau, J.Y., Watt, R.M., Jin, L.J., Samaranayake, L.P., Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation. J Med Microbiol 58 (2009), 1623–1631.
57. [57] Cruz, M.R., Graham, C.E., Gagliano, B.C., Lorenz, M.C., Garsin, D.A., Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans. Infect Immun 81 (2013), 189–200.
58. [58] Falagas, M.E., Betsi, G.I., Athanasiou, S., Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother 58 (2006), 266–272.
59. [59] Nobbs, A.H., Jenkinson, H.F., Interkingdom networking within the oral microbiome. Microbes Infect 17 (2015), 484–492.
60. [60] Bamford, C.V., Nobbs, A.H., Barbour, M.E., Lamont, R.J., Jenkinson, H.F., Functional regions of Candida albicans hyphal cell wall protein Als3 that determine interaction with the oral bacterium Streptococcus gordonii. Microbiology 161 (2015), 18–29.
61. [61] Strus, M., Kucharska, A., Kukla, G., Brzychczy-Włoch, M., Maresz, K., Heczko, P.B., The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol 13 (2005), 69–75.
62. [62] Fox, E.P., Cowley, E.S., Nobile, C.J., Hartooni, N., Newman, D.K., Johnson, A.D., Anaerobic bacteria grow within Candida albicans biofilms and induce biofilm formation in suspension cultures. Curr Biol 24 (2014), 2411–2416.
63. [63] Xie, Z., Thompson, A., Sobue, T., Kashleva, H., Xu, H., Vasilakos, J., et al. Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing. J Infect Dis 206 (2012), 1936–1945.
64. [64] Ghosh, S., Navarathna, D.H.M.L.P., Roberts, D.D., Cooper, J.T., Atkin, A.L., Petro, T.M., et al. Arginine-induced germ tube formation in Candida albicans is essential for escape from murine macrophage line RAW 264.7. Infect Immun 77 (2009), 1596–1605.
65. [65] Gropp, K., Schild, L., Schindler, S., Hube, B., Zipfel, P.F., Skerka, C., The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol Immunol 47 (2009), 465–475.
66. [66] Dwivedi, P., Thompson, A., Xie, Z., Kashleva, H., Ganguly, S., Mitchell, A.P., et al. Role of Bcr1-activated genes Hwp1 and Hyr1 in Candida albicans oral mucosal biofilms and neutrophil evasion. PLoS One, 6, 2011, e16218.
67. [67] Naglik, J.R., Challacombe, S.J., Hube, B., Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 67 (2003), 400–428.
68. [68] Ene, I.V., Adya, A.K., Wehmeier, S., Brand, A.C., MacCallum, D.M., Gow, N.A.R., et al. Host carbon sources modulate cell wall architecture, drug resistance and virulence in a fungal pathogen. Cell Microbiol 14 (2012), 1319–1335.
69. [69] Linden, S.K., Sutton, P., Karlsson, N.G., Korolik, V., McGuckin, M.A., Mucins in the mucosal barrier to infection. Mucosal Immunol 1 (2008), 183–197.
70. [70] Kavanaugh, N.L., Zhang, A.Q., Nobile, C.J., Johnson, A.D., Ribbeck, K., Mucins suppress virulence traits of Candida albicans. MBio, 5, 2014, e01911.
71. [71] Mukherjee, P.K., Chandra, J., Kuhn, D.M., Ghannoum, M.A., Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 71 (2003), 4333–4340.
72. [72] Ramage, G., Bachmann, S., Patterson, T.F., Wickes, B.L., Lopez-Ribot, J.L., Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 49 (2002), 973–980.
73. [73] Anderson, J.B., Evolution of antifungal-drug resistance: mechanisms and pathogen fitness. Nat Rev Microbiol 3 (2005), 547–556.
74. [74] Cowen, L.E., The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype. Nat Rev Microbiol 6 (2008), 187–198.
75. [75] Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., et al. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 51 (2007), 510–520.
76. [76] Vediyappan, G., Rossignol, T., D'Enfert, C., Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans. Antimicrob Agents Chemother 54 (2010), 2096–2111.
77. [77] Mathe, L., Van Dijck, P., Mathé, L., Van Dijck, P., Recent insights into Candida albicans biofilm resistance mechanisms. Curr Genet 59 (2013), 251–264.
78. [78] LaFleur, M.D., Kumamoto, C.A., Lewis, K., Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 50 (2006), 3839–3846.